Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
International Journal of Hematology
|
June 14, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
Satsuki Murakami, Masaki Ri, Masato Ito, et al.
Cancer Medicine
|
April 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
International Journal of Hematology
|
February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Cancer Science
|
September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study
Kazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 27, 2025
[Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies]
Yasunori Kogure, Yuji Oshikawa-Kumade, Suguru Fukuhara, et al.
Leukemia Research
|
November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma
Atsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 4, 2023
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy]
Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, et al.
Blood
|
March 1, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
Yasunori Kogure, Hiroshi Handa, Yuta Ito, et al.
British Journal of Haematology
|
May 10, 2020
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
Takashi Kanamori, Masashi Sanada, Masaki Ri, et al.
Ejhaem
|
September 2, 2022
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan
Yurie Miyamoto-Nagai, Naoya Mimura, Nobuhiro Tsukada, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
International Journal of Hematology
|
June 14, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
Satsuki Murakami, Masaki Ri, Masato Ito, et al.
Cancer Medicine
|
April 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
International Journal of Hematology
|
February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Cancer Science
|
September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study
Kazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 27, 2025
[Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies]
Yasunori Kogure, Yuji Oshikawa-Kumade, Suguru Fukuhara, et al.
Leukemia Research
|
November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma
Atsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 4, 2023
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy]
Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, et al.
Blood
|
March 1, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
Yasunori Kogure, Hiroshi Handa, Yuta Ito, et al.
British Journal of Haematology
|
May 10, 2020
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
Takashi Kanamori, Masashi Sanada, Masaki Ri, et al.
Ejhaem
|
September 2, 2022
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan
Yurie Miyamoto-Nagai, Naoya Mimura, Nobuhiro Tsukada, et al.
Page
of 12